[Comparative antioxidant and antihypoxic activities of new 1,4-dihydro-4-oxopyrimidine derivative--compound PDMpT.HCl and mexidol]

Eksp Klin Farmakol. 2013;76(6):38-40.
[Article in Russian]

Abstract

Compound PDMpT.HCI reduces intensity of lipoperoxidation, activates antioxidant system and increases animal life expectancy under hypoxic circumstance.

Publication types

  • Comparative Study

MeSH terms

  • Animals
  • Animals, Outbred Strains
  • Antioxidants / chemistry
  • Antioxidants / pharmacology*
  • Gravitation
  • Hypoxia-Ischemia, Brain / drug therapy*
  • Hypoxia-Ischemia, Brain / metabolism
  • Hypoxia-Ischemia, Brain / physiopathology
  • Lipid Peroxidation / drug effects
  • Longevity / drug effects
  • Male
  • Mice
  • Picolines / pharmacology
  • Pyrimidines / chemistry
  • Pyrimidines / pharmacology*
  • Pyrimidinones / chemistry
  • Pyrimidinones / pharmacology*
  • Rats
  • Reperfusion Injury / drug therapy*
  • Reperfusion Injury / metabolism
  • Reperfusion Injury / physiopathology
  • Superoxide Dismutase / metabolism
  • Toluene / analogs & derivatives*
  • Toluene / chemistry
  • Toluene / pharmacology

Substances

  • 2,6-dimethyl-5-phenyl-1-p-tolyl-1H-pyrimidin-4-one
  • Antioxidants
  • Picolines
  • Pyrimidines
  • Pyrimidinones
  • emoxypine succinate
  • Toluene
  • Superoxide Dismutase